Answers are grounded in this paper and cite their sources.
BACKGROUND & OBJECTIVE: gene amplification by chromogenic in situ hybridization (CISH) in IHC Her2 (2+) breast cancer individuals. METHODS: A cross-sectional study was conducted in Zaferanyeh Laboratory collaborated with Shahid Beheshti University of Medical Sciences (Tehran-Iran; 2015-2018). All pathological data related invasive breast cancer patients with equivocal IHC results were included. CISH method was performed as a supplementary technique. The associations between histopathologic variables, status of Ki-67 index, progesterone and estrogen receptors (PR & ER) with her2 amplification by CISH were investigated and analyzed. The level of significance was considered as P-value < 0.05. RESULTS: gene amplification in 51 subjects (21.3%). The type of tumor (invasive ductal carcinoma), the tumor grade, and the value of Ki-67 index were directly correlated with her2 amplification. Significant negative associations were also observed between CISH results and ER and PR expression. CONCLUSION: amplification.
No takes yet. Share an insight, caveat, or question.
Hashemi-Bahremani et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: